« Iran May Agree To Demand For Suspension Of It's Uranium Activities | Main | Former President Carter On Arafat, "A Powerful Human Symbol" »
November 12, 2004
Access Cardiosystems, Inc. Issues a Worldwide Recall of Automated External Defibrillators (AED'S)
Topics: Clinical PharmacologyFDA Report.
Contact: Recall Coordinator, 1-978-405-1057
FOR IMMEDIATE RELEASE --Concord, MA-- Nov. 10, 2004 -- Access CardioSystems, Inc., Concord, Massachusetts, initiated a voluntary recall of all of its Automated External Defibrillators (AED's). Additionally, for reasons beyond its control, the Company is no longer doing business.
We have identified two potential problems with certain AED's that warrant your immediate attention:
1. Potential Failure of the Shock Delivery Circuit:
The Company is aware of a situation involving certain of its AEDs in which the device may experience a catastrophic failure of the shock delivery circuit. The Company's investigation indicates to date that this failure mode is restricted to a specific batch of one device component. To date, the company has received 11 complaints of this occurrence in devices containing the component shown to be associated with this failure mode (representing a 0.8% complaint rate within the affected units). When this potential problem occurs, it is not possible to deliver additional defibrillation shocks.
Although the investigation of this issue is still ongoing, the Company has determined that AEDs with the following serial numbers may have this problem: 075690 - 077140.
Posted by Hyscience at November 12, 2004 12:33 AM
Articles Related to Clinical Pharmacology:
- Britain tests first Cannabis related medicine for rheumatoid arthritis - Nov 13, 2005
- Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma - May 26, 2005
- Cystatin C May Push Creatinine Off Risk Radar - May 19, 2005
- Cancer Treatment Success Stuns Scientists - May 16, 2005
- Antibody, cancer drug combo shows promise against breast tumors - May 16, 2005
- USC researchers determine mechanism of action of motexafin gadolinium (Xcytrin) - May 02, 2005
- Herceptin® Combined With Chemotherapy Improves Disease-Free Survival for Patients With Early-Stage Breast Cancer - Apr 26, 2005
- Selenium will have critical role in prostate cancer treatment - Fox Chase Cancer Center - Apr 21, 2005
- Traditional Medicine Derivatives Kill Cancer Cells - Apr 20, 2005
- Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds - Apr 19, 2005
